Human Pharmaceutical Portfolio

Mabura 40 mg PFS

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthAdalimumab 40 mg
ManufacturerHetero Healthcare Ltd
CategoryArthritis
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.